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The Right Prediction*
John P. Boehmer, MD
Hershey, Pennsylvania
Despite much improvement in the outcomes of patients
undergoing implantation with left ventricular assist devices
(LVADs), right ventricle (RV) failure remains a challenging
clinical dilemma, particularly perioperatively as a significant
cause of morbidity and mortality (1). In the patient freshly
implanted with an LVAD, the RV becomes the limiting
step to increase forward cardiac output. With increasing
right atrial pressures in a failing RV, along with poor
forward flow and, thereby, blood pressure, organ perfusion
is compromised, leading to multiple organ dysfunction.
Accordingly, many clinical investigators who work in this
area have attempted to assess RV function pre-operatively,
so as to either better select appropriate candidates for
LVAD support, mitigate the impact of poor RV function
post-operatively, or allow planning for interventions such as
RV assist devices.
See page 521
However, assessing RV function is challenging. The RV
has an unusual shape, making quantitation of RV volumes
challenging. In patients with normal physiology, low pul-
monary arterial pressures require relatively low stroke work
in the RV. Chronic heart failure typically increases loading
conditions on the RV, and the RV becomes conditioned to
increase stroke work. Unfortunately, a number of factors
then combine to cause RV dysfunction post-operatively.
Even under optimal conditions, cardiopulmonary bypass
may cause transient depression of RV function. Further-
more, the RV is uniquely susceptible to air embolism, with
much of its blood supply typically coming from the right
coronary artery, which is anatomically the more superior
artery as the heart is being de-aired. Cardiopulmonary
bypass often leads to transient increases in pulmonary
vascular resistance, causing further increases in afterload on
the RV. Blood products along with colloid and crystalloid
solutions add to the loading conditions on the RV. Finally,
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shift of the interventricular septum toward the left. The
LV–RV interactions cause unusual loading conditions on
the septum and may lead to further impairment of global
RV function.
In this issue of the Journal, Grant et al. (2) describe the
use of velocity vector imaging of RV free wall longitudinal
strain to predict post-operative RV failure after LVAD
implantation. The authors are an experienced group with a
fairly high volume of implantations. They use a reasonably
complete set of variables in this work that have been
reported to be useful in the prediction of RV failure.
Therefore, they provide a fair comparison with what has
been done previously. A number of variables were associated
with an increased risk for RV failure. These included
hemodynamic parameters (right atrial pressure and pulmo-
nary vascular resistance), clinical parameters (inotrope use),
and biochemical measurements (total bilirubin). The au-
thors also use a previously reported composite to predict RV
failure, the Michigan RV risk score (3). The Michigan RV
risk score was derived from a multivariable analysis of their
single-center population. The variables included in the risk
score are clinical (vasopressor use) and biochemical (elevated
aspartate aminotransferase, total bilirubin, and creatinine).
The echocardiographic parameters correlated with RV fail-
ure were the subjective assessment of RV systolic function
and RV free wall longitudinal strain. When added to the
Michigan RV risk score, RV longitudinal strain had an
incremental benefit.
The authors do a commendable job of describing the
limitations of their work. They deal in detail with the
percentage of patients who did not have acceptable images,
which will obviously affect the wider applicability of the
method. Additionally, this was a single-center study, and
the reproducibility of their findings in other centers has not
been assessed. However, because the study was retrospec-
tive, the images obtained during routine clinical practice
may be improved with further work.
Another issue is that local practices for the selection of
LVAD candidates and their management before and after
surgery are not uniform. For example, the right atrial
pressures of the population in this study ranged only from 6
to 15 mm Hg, suggesting that patients were either aggres-
sively treated or screened pre-operatively to create this
unusual finding for an advanced heart failure population.
Furthermore, the authors report an incidence of RV failure
that is at the upper end of what has been reported in the
literature. It may be that their population was unusually ill
or had poor RV function pre-operatively. However, it would
appear more likely that this particular group of clinicians
monitored RV function closely and treated RV failure
aggressively. Therefore, the definition of RV failure used,
while an accepted definition used in prior similar studies,
may be flawed in that the definition relies heavily on a
physician’s reaction to a patient’s condition more so than
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such a definition falls immediately back to the original
problem—that RV function is difficult to measure. Because
each program is unique, assessing the utility of these
parameters in multiple centers is necessary to make certain
that the findings apply to various practices.
A number of other echocardiographic parameters have
been evaluated for this purpose. Matthews et al. (3) reported
8 echocardiographic parameters included in the develop-
ment of the Michigan RV risk score. However, the data
were collected retrospectively, and sophisticated measures of
RV mechanics were not routine. Another recent publica-
tion, by Topilsky et al. (4), found that a decrease in the
timing interval between the onset and the cessation of
tricuspid regurgitation flow corrected for heart rate pre-
dicted adverse outcomes following LVAD implantation. A
number of other studies using fewer variables in their
analyses have found clinical, biochemical, hemodynamic,
and echocardiographic parameters to be useful in their
populations. However, there has been no report from larger,
multicenter cohorts to confirm the utility of many of these
metrics.
The authors should be commended for their work to
increase our knowledge on the prediction of RV failure in
the LVAD recipient. More work is needed to determine
whether these findings can be applied to other centers with
different imaging and clinical practices. Additionally, more
work needs to be done to improve outcomes in high-risk
patients once they are identified. A number of studies have
now reported improving perioperative survival with our
current methods (5,6). Further improvements may involve
more aggressive use of mechanical support of the RV, novelmechanic support devices, and/or novel pharmacologic ther-
apy, or patient selection should simply be refined. However,
as progress is made in the perioperative management of the
LVAD recipient, better prediction of RV failure will be-
come more important in selection and management deci-
sions. This issue is vital because getting the prediction right
is critically important to outcomes in LVAD candidates.
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